BCL2 and prostate carcinoma: miR-205/31 could suppress the expression of BCL2/E2F6 respectively, and improving the apoptosis of prostate cancer induced by chemotherapy. The downexpression of miR-205/miR-31 plays an important role in the anti-apoptotic function of tumor.